Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

Agüero, F. ; Forner, A. ; Manzardo, C. ; Valdivieso, A. ; Blanes, M. ; Barcena, R. ; Rafecas, A. ; Castells, L. ; Abradelo, M. ; Torre-Cisneros, J. ; Gonzalez-Dieguez, L. ; Salcedo, M. ; Serrano, T. (Universidad de Zaragoza) ; Jimenez-Perez, M. ; Herrero, J. I. ; Gastaca, M. ; Aguilera, V. ; Fabregat, J. ; del Campo, S. ; Bilbao, I. ; Romero, C. J. ; Moreno, A. ; Rimola, A. ; Miro, J. M. ; Miro, J. M. [...] Afficher les 204 auteurs
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Resumen: The impact of human immunodeficiency virus (HIV) infection on patients undergoing liver transplantation (LT) for hepatocellular carcinoma (HCC) is uncertain. This study aimed to assess the outcome of a prospective Spanish nationwide cohort of HIV-infected patients undergoing LT for HCC (2002-2014). These patients were matched (age, gender, year of LT, center, and hepatitis C virus (HCV) or hepatitis B virus infection) with non-HIV-infected controls (1:3 ratio). Patients with incidental HCC were excluded. Seventy-four HIV-infected patients and 222 non-HIV-infected patients were included. All patients had cirrhosis, mostly due to HCV infection (92%). HIV-infected patients were younger (47 versus 51 years) and had undetectable HCV RNA at LT (19% versus 9%) more frequently than non-HIV-infected patients. No significant differences were detected between HIV-infected and non-HIV-infected recipients in the radiological characteristics of HCC at enlisting or in the histopathological findings for HCC in the explanted liver. Survival at 1, 3, and 5 years for HIV-infected versus non-HIV-infected patients was 88% versus 90%, 78% versus 78%, and 67% versus 73% (P = 0.779), respectively. HCV infection (hazard ratio = 7.90, 95% confidence interval 1.07-56.82) and maximum nodule diameter >3 cm in the explanted liver (hazard ratio = 1.72, 95% confidence interval 1.02-2.89) were independently associated with mortality in the whole series. HCC recurred in 12 HIV-infected patients (16%) and 32 non-HIV-infected patients (14%), with a probability of 4% versus 5% at 1 year, 18% versus 12% at 3 years, and 20% versus 19% at 5 years (P = 0.904). Microscopic vascular invasion (hazard ratio = 3.40, 95% confidence interval 1.34-8.64) was the only factor independently associated with HCC recurrence. Conclusions: HIV infection had no impact on recurrence of HCC or survival after LT. Our results support the indication of LT in HIV-infected patients with HCC.
Idioma: Inglés
DOI: 10.1002/hep.28321
Año: 2016
Publicado en: HEPATOLOGY 63, 2 (2016), 488-498
ISSN: 0270-9139

Factor impacto JCR: 13.246 (2016)
Categ. JCR: GASTROENTEROLOGY & HEPATOLOGY rank: 4 / 79 = 0.051 (2016) - Q1 - T1
Factor impacto SCIMAGO: 5.229 - Medicine (miscellaneous) (Q1) - Hepatology (Q1)

Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
Exportado de SIDERAL (2024-01-24-14:59:22)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
articulos > articulos-por-area > medicina



 Notice créée le 2024-01-24, modifiée le 2024-01-24


Versión publicada:
 PDF
Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)